Hey There : )
Unlisted Shares
Price Chart
1W
1M
1Y
MAX
High
-
Low
-
Return
-
Medikabazaar Essentials
As of September 08, 2024, Medikabazaar (Boston Ivy Healthcare Solutions), Unlisted share price is ₹None per share and the face value is ₹1.00/share. The lot size of Medikabazaar (Boston Ivy Healthcare Solutions) is None shares. The 52-week high for Medikabazaar (Boston Ivy Healthcare Solutions) stock price is ₹None, while the 52-week low is ₹None
An International Securities Identification Number (ISIN) is a code that uniquely identifies a specific securities issue. The numbers are allocated by a country's respective national numbering agency (NNA).
Value of a security, as stated by its issuer. It has no relation with market price of the stock.
Total shares or total number of shares outstanding represents the amount of stock on the open market, including shares held by institutional investors and restricted shares held by insiders and company officers.
A sector is an area in which businesses share the same or a related product or service. It can also be known as an industry or market that shares common operating characteristics
Subsectors are the divisions of a sector. They are areas that vary from the rest of the sector substantially enough to justify creating a plan just for the subsector.
Category is defined as a class or division of things regarded as having particular shared characteristics.
Medikabazaar Growth
Compounded Sales Growth
Highlights
- Largest selection of medical supplies in India: Medikbazaar offers a wide range of medical supplies, including surgical instruments, diagnostic equipment, pharmaceuticals, and consumables. Medikbazaar is known for its focus on customer service, providing its customers with technical support, logistics assistance, and after-sales service.
- Financial Highlights: Surprisingly, the company's revenue surged from ₹565 Cr in FY21 to ₹1553 Cr in FY22, marking a staggering growth of 179%. However, despite this growth, the company's net margin declined from a profit of ₹3 Cr in FY21 to a loss of ₹21 Cr in FY22. This shift is primarily attributed to increased expenses in stock-in-trade purchases and Depreciation & Amortization.
- Investment and Growth Potential: An interesting fact might be that Boston Ivy received investment from British International Investment (now known as BII) in 2013. This investment aimed to support Medikbazaar's growth, particularly in reaching smaller healthcare providers in non-metro areas of India. This suggests that Boston Ivy is focused on expanding Medikbazaar's reach and impact.
Business Rating
Our Team
